Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)

[ad_1]

Interview with Dr. Allen Davidoff, CEO

Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. Dr. Davidoff also talked about their other key programs and the major milestones Xortx hopes to accomplish this year.

INTERVIEW TRANSCRIPTS:


The Wall Street Analyzer’s staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.



[ad_2]
Written by The Wall Street Analyzer.
View the original article at here.
The Wall Street Analyzer
wallstreetanalyzer.com

Recommended